Why the study?
Although cryoballoon ablation and pulsed field ablation are both single-shot techniques for first-time pulmonary vein isolation, comparative real-world evidence from large cohorts remained limited.
Population
1,961 consecutive patients undergoing index PVI at a German tertiary referral center
Comparison
Pulsed field ablation using a pentaspline catheter (n=592) vs cryoballoon ablation (n=1,369)
Design
Single-center retrospective observational cohort analysis
Follow-up
Median 1,076 days
Answers are grounded in this paper and cite their sources.
Similar recurrence after PFA versus cryoballoon ablation should not change practice; leaves open durability impact in prospective trials.
Background Cryoballoon (CB) ablation has been an established single-shot technique for first-time pulmonary vein isolation (PVI), whereas pulsed field ablation (PFA) is being increasingly adopted in clinical practice. Although both technologies are designed to facilitate efficient PVI, comparative real-world evidence from large cohorts remains limited. Methods We conducted a retrospective analysis of consecutive patients undergoing index pulmonary vein isolation (PVI) at a high-volume German tertiary referral center between 2021 and 2025. Clinical baseline characteristics, procedural metrics, and acute safety outcomes were collected using a standardized approach and subsequently analyzed. The primary efficacy endpoint was the recurrence of atrial tachyarrhythmia, documented by ECG or Holter monitoring after completion of a prespecified 90-day blanking period. Secondary endpoints included acute procedural efficacy and safety, early atrial tachyarrhythmia recurrence during the blanking period, and the durability of pulmonary vein isolation (PVI), determined by high-density electroanatomical remapping at the time of repeat ablation. Results A total of 1,961 patients were included in the analysis, of whom 1,369 underwent cryoballoon (CB) ablation and 592 underwent pulsed field ablation (PFA) using a pentaspline catheter. Baseline characteristics were comparable between groups with respect to sex, age, atrial fibrillation (AF) type, left ventricular ejection fraction, history of stroke/transient ischemic attack (TIA), antiarrhythmic drug therapy, and anticoagulation status. Median procedure duration was shorter in the PFA group compared with the CB group (46 [Q1–Q3: 40–55] vs. 75 [60–85] minutes; p<0.001). Acute safety outcomes were similar between groups. Major complications occurred in 0.8% of CB procedures and 0.5% of PFA procedures (p=0.77), while minor complications were observed in 1.2% and 0.4% of procedures, respectively (p=0.091). During a median follow-up of 1,076 days (95% confidence interval [CI] 972–1,243), the incidence of atrial tachyarrhythmia recurrence beyond the 90-day blanking period did not differ significantly between groups (hazard ratio [HR] 1.02, 95% CI 0.804–1.294; p=0.827). Repeat ablation was performed in 204 patients (10.4%), including 169 of 1,369 patients (12.3%) in the CB group and 35 of 592 patients (5.9%) in the PFA group. Among patients undergoing repeat procedures, complete pulmonary vein (PV) isolation at high-density remapping was observed more frequently following PFA than following CB ablation (45.7% vs. 22.5%; p=0.01). Reconnection rates in the right superior and right inferior PVs were lower after PFA compared with CB ablation (14.3% vs. 50.3% and 14.3% vs. 48.5%, respectively; both p<0.001). Conclusion In this large real-world cohort, both CB and PFA were associated with favorable acute safety profiles and comparable long-term freedom from atrial tachyarrhythmia recurrence. PVI durability differed between treatment modalities, with PFA demonstrating a higher proportion of complete pulmonary vein isolation using high-density remapping compared with CB ablation.
No takes yet. Share an insight, caveat, or question.
My et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: